BT-1000

FDA 510(k) K232991 · Bistos Co., Ltd.

Substantially Equivalent

510(k) numberK232991

Submission

Device name
BT-1000
Applicant
Bistos Co., Ltd.
Gyeonggi, KR
Received
September 22, 2023
Decision date
August 28, 2024
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QGL – Transcutaneous Nerve Stimulator For Adhd
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5898
Specialty
Neurology

A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.

Other 510(k)s with product code QGL

510(k)DeviceApplicantDecision
K243289Addnox (BPSPM1)QGL · Traditional Nu Eyne Co., Ltd.01/16/2025SE
K233293Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®QGL · Traditional Neurosigma, Inc.01/16/2024SE
K213629SmileQGL · Traditional Nu Eyne Co., Ltd.02/12/2023SE

More from Nu Eyne Co., Ltd.

510(k)DeviceDecision
K251512Hi bebe super (BT-150B)HGX · Special 09/25/2025SE
K210289Infant Phototherapy EquipmentLBI · Traditional 05/28/2021SE
K200675Hi bebe super (Models BT-150S and BT-150L)HGX · Special 02/10/2021SE
K160274Hi bebe plusHGX · Traditional 09/01/2016SE
K142799Model BT-220L and BT-220CHGM · Traditional 07/09/2015SE
K132543Infant IncubatorFMZ · Traditional 07/03/2014SE
K121267BT-200V Vascular DopplerHGM · Traditional 08/02/2012SE
K103545BT-350HGM · Traditional 05/13/2011SE
K100885Fetal Monitor Model: BT-200THGM · Traditional 06/07/2010SE
K052190Fetal Monitor, Models BT-300 and BT-200HGM · Traditional 10/04/2005SE

Questions and answers

When was BT-1000 cleared by the FDA?

BT-1000 (K232991) received a 510(k) decision of Substantially Equivalent on August 28, 2024, 341 days after the submission was received.

What is the product code of K232991?

The FDA product code is QGL – Transcutaneous Nerve Stimulator For Adhd, a Class II (moderate risk) device regulated under 21 CFR 882.5898.